Showing 21 - 40 results of 255 for search '(( 37 c decrease ) OR ( 10 (((meer OR peter) decrease) OR (((nn decrease) OR (mean decrease)))) ))*', query time: 0.16s Refine Results
  1. 21
  2. 22
  3. 23
  4. 24
  5. 25

    Preparation and characterization of wollastonite/titanium oxide nanofiber bioceramic composite as a future implant material by Aly, Ibrahim H.M.

    Published 2016
    “…These materials were characterized and investigated by means of physical, mechanical and in vitro studies. …”
    Get full text
    Get full text
    Get full text
  6. 26
  7. 27

    Partial characterization Of an alkalophilic extracellular Crude pectinases from a bacillus Polymyxa strain by Al Rajabi, Ihab. I. [ايهاب الرجبي وعادل محاسنه]

    Published 1999
    “…This bacterium grew best at 37°C and pH 7.0 and was able to produce extracellular enzymes other than pectinases, e.g.: protease, amylases, and cellulases. …”
    Get full text
  8. 28
  9. 29
  10. 30
  11. 31
  12. 32
  13. 33

    Enzymatic treatment of peanut butter to reduce the concentration of major peanut allergens by Yu, Jianmei

    Published 2013
    “…Home-made and commercial peanut butter samples were treated with alpha-chymotrypsin, trypsin or the combination of these enzymes and incubated at room temperature for 24 h or at 37 °C for 3 h. Treated peanut butter samples were sampled weekly for evaluation of total soluble proteins and extractable Ara h 1/Ara h 2. …”
    Get full text
    Get full text
  14. 34
  15. 35

    Production of phycocyanin by Leptolyngbya sp. in desert environments by Schipper, Kira

    Published 2020
    “…The optimum biomass productivity was found at a light intensity of 300 μmol·m−2·s−1, with higher light intensities causing a decrease of 15%. Furthermore, of the various phycocyanin extraction methods tested, bead-beating in phosphate buffer had the highest combined phycocyanin yield (169.9 ± 3.6 mgPC·gX) and purity (7.37 ± 0.16) for Leptolyngbya sp. …”
    Get full text
    Get full text
    Get full text
  16. 36
  17. 37

    Understanding the mechanisms mediating cardio-renal benefit of empagliflozin in type 2 diabetes mellitus by Dimitrios, Patoulias

    Published 2023
    “…They have demonstrated1 that empagliflozin treatment resulted in a significant decrease in pulse pressure (PP), mean arterial pressure (MAP) and cardiac workload, compared with placebo; at week 12, placebo-adjusted mean changes from baseline were − 2.5 mmHg for PP, − 2.2 mmHg for MAP and − 315 mmHg x beats per minute (bpm) for cardiac workload (p < 0.0001 for all). …”
    Get full text
    Get full text
    Get full text
  18. 38

    Impact of pharmacist-involved collaborative care on diabetes management in a primary healthcare setting using real-world data by Abdulrhim, Sara

    Published 2022
    “…Results After 17 months of follow-up, pharmacist-involved collaborative care compared to usual care resulted in a significant decrease in HbA1c (6.8 ± 1.2% vs. 7.1 ± 1.3%, p < 0.01). …”
    Get full text
    Get full text
  19. 39
  20. 40